Search is Powered by Google
Cancer / Oncology News

Researchers Study Groups Of Genes Working Together To Cause Cancer

rate icon Editor's Choice
Main Category: Cancer / Oncology
Also Included In: Biology / Biochemistry;  Pharma Industry / Biotech Industry;  Genetics
Article Date: 15 Feb 2008 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Scientists are discovering more about cancer using a method that finds connections between the genetic pathways involved. Researchers from Duke University's Institute for Genome Sciences & Policy started with familiar gene sets that cooperate to promote cancer development and used a new statistical technique to scan for any links or dependencies between them. These findings were reported on February 15, 2008 in the open-access journal PLoS Computational Biology, a part of the Public Library of Science.

Sayan Mukherjee, a co-author of the study, highlighted the breakthrough this implies: "Our major innovation is the use of gene sets in modeling tumor progression rather than single genes." The model permitted characterization of gene networks over time as the cancer progressed: from normal tissue to early cancerous tissue to metastasis or spread.

"We'd like to know why cancer goes metastatic," said Mukherjee. "Primary cancer can often be dealt with fairly well, so the real goal is to understand what happens when it spreads. My hope is that we could give these maps to a clinician and be able to tell them 'This is what it looks like.'"

How each genetic pathway fits into the broad picture of cancer could allow physicians to select drug targets more efficiently. For example, one drug could target a pathway that links several pathways together, acting as a kind of central support for the rest of the network. Or, according to Mukherjee, if the genes involved with one particular type of cancer were to instead fall into individual clustered, treatments could be developed to target each one individually.

Additionally, the authors see potential future for this method to develop models of cancers in other areas, such as the study of embryonic development.

The work was supported by the Damon Runyon Cancer Research Foundation, the National Science Foundation and the National Institutes of Health.

About PLoS Computational Biology

PLoS Computational Biology (www.ploscompbiol.org) features works of exceptional significance that further our understanding of living systems at all scales through the application of computational methods. All works published in PLoS Computational Biology are open access. Everything is immediately available subject only to the condition that the original authorship and source are properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

About the Public Library of Science

The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org.

Modeling cancer progression via pathway dependencies

Edelman EJ, Guinney J, Chi JT, Febbo PG, Mukherjee S
PLoS Comput Biol 4(2): e28.
doi:10.1371/journal.pcbi.0040028
Click Here For Full Text

Written by Anna Sophia McKenney
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...